Financial News
Latest News about SRDX
Recent news which mentions SRDX
Stocks That Hit 52-Week Lows On Monday
March 06, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
February 28, 2023
From Benzinga
Abbott-Cardiovascular Systems Acquisition Could Further Add Uncertainty Over Surmodics' Product: Analyst Downgrades Stock
February 13, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 13, 2023
February 13, 2023
From Benzinga
Earnings Scheduled For February 6, 2023
February 06, 2023
From Benzinga
Dow Drops 150 Points; Crude Oil Up 1%
January 19, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
January 19, 2023
From Benzinga
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 19, 2023
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 19, 2023
From Benzinga
Nasdaq Down Over 100 Points; Procter & Gamble Posts In-Line Earnings
January 19, 2023
From Benzinga
Dow Falls 200 Points; Jobless Claims Drop To 4-Month Low
January 19, 2023
From Benzinga
Surmodics Stock Slides Following Regulatory Setback For Its SurVeil Drug-Coated Balloon
January 19, 2023
Tickers
SRDX
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 19, 2023
From Benzinga
Earnings Scheduled For July 27, 2022
July 27, 2022
From Benzinga
Earnings Scheduled For April 27, 2022
April 27, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 03, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 03, 2022
From Benzinga
Earnings Scheduled For February 3, 2022
February 03, 2022
From Benzinga
Surmodics Inc (SRDX) Q4 2021 Earnings Call Transcript
November 10, 2021
Tickers
SRDX
From Motley Fool
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
From Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
